These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4332732)

  • 1. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
    Namba T
    Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular block after intra-arterially injected acetylcholine. 2. Effects of ACTH treatments as possible detectors of desensitization level in the receptor site.
    Pinelli P; Tonali P; Gambi D
    J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):271-4. PubMed ID: 4350704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of ACTH and corticosteroids in myasthenia gravis.
    Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG
    Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antibodies against skeletal muscle constituents on muscle function in rats.
    Namba T; Grob D
    Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure.
    Engel AG; Lambert EH; Santa T
    Neurology; 1973 Dec; 23(12):1273-81. PubMed ID: 4357114
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of germine acetates on neuromuscular transmission.
    Brennan JL; Jones SF; McLeod JG
    J Neurol Sci; 1971 Jul; 13(3):321-31. PubMed ID: 4330354
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE
    Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apropos of the pathogenesis of myasthenia gravis].
    Dolzhenko AT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(3):393-8. PubMed ID: 4299667
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.
    Namba T; Brunner NG; Shapiro MS; Grob D
    Neurology; 1971 Oct; 21(10):1008-18. PubMed ID: 4329627
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnosis and management of myasthenia gravis.
    Walsh JC
    Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Grob test in myasthenia: discussion of an atypical case].
    Gambi D; Tonali P
    Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238
    [No Abstract]   [Full Text] [Related]  

  • 12. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
    Brunner NG; Namba T; Grob D
    Neurology; 1972 Jun; 22(6):603-10. PubMed ID: 4343255
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of prostigmin on the basal electromyogram in myasthenia.
    Wochnik-Dyjas D; Niewiadomska M
    Pol Med J; 1970; 9(4):932-8. PubMed ID: 4320112
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 18. Sites of action of gerine diacetate in myasthenia gravis.
    Flacke W; Caviness VS; Samaha F; Schwab RS
    Trans Am Neurol Assoc; 1967; 92():158-62. PubMed ID: 5634017
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylcholine release from motor-nerve endings in rats treated with neostigmine.
    Roberts DV; Thesleff S
    Eur J Pharmacol; 1969; 6(3):281-5. PubMed ID: 4308016
    [No Abstract]   [Full Text] [Related]  

  • 20. Hazard from antibiotics in myasthenia gravis.
    McQuillen MP
    Ann Intern Med; 1970 Sep; 73(3):487-8. PubMed ID: 4318447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.